Loading clinical trials...
Loading clinical trials...
In patients treated with direct oral anticoagulants, bleeding events during or after tooth extraction can lead to unscheduled interruption of the antithrombotic treatment and a potential increased risk of thrombo-embolic events. Therefore, an optimal strategy to minimize bleeding events after tooth extractions is required. In this study, the investigators want to assess whether adding tranexamic acid mouthwash reduces the number of bleeding events in patients treated with direct oral anticoagulants and undergoing a tooth extraction.
Interventional phase IV, randomized, double-blind, placebo-controlled trial: * Feasibility: a 3-day regimen of tranexamic acid mouthwash in patients treated with direct oral anticoagulants * Efficacy: reduction of bleeding events after tooth extraction compared to placebo * Safety: any non-oral bleeding or thrombo-embolic events
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospitals Leuven
Leuven, Belgium
Start Date
February 7, 2018
Primary Completion Date
March 19, 2020
Completion Date
March 19, 2020
Last Updated
August 1, 2024
222
ACTUAL participants
Tranexamic Acid
DRUG
Placebo
OTHER
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
NCT06552936
NCT06724783
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06275191